Who Paid My Doc
Lucy Ibrahim
Addiction Medicine Romeoville, IL Medical Doctor
NPI 1184610107 CMS profile 567429
1280 Windham Pkwy, Romeoville, IL 60446
General payments
$363
Research payments
$0
Ownership & investment interest
$18,115,049
Through program year 2022, Lucy Ibrahim of Romeoville, IL is reported in the CMS Open Payments database as having received $363 across 19 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $18,115,049 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 57th percentile of Addiction Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $22 | 1 | |
| 2020 | General | $86 | 4 | |
| 2019 | General | $255 | 14 | |
| 2025 | Ownership | $2,994,223 | 1 | |
| 2024 | Ownership | $2,994,223 | 1 | |
| 2023 | Ownership | $2,994,223 | 1 | |
| 2022 | Ownership | $2,994,223 | 1 | |
| 2021 | Ownership | $2,994,223 | 1 | |
| 2020 | Ownership | $3,143,934 | 1 |
Beside peers
- Lucy Ibrahim
- Addiction Medicine median
- Middle half of Addiction Medicine
- National median
In program year 2025, general payments to Lucy Ibrahim were reported at $0. Among 146 Addiction Medicine profiles paid that year, the median was $140 and the middle half received between $52 and $540.
Show as a table
| Year | Lucy Ibrahim | Addiction Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $255 | $120 | $36–$323 | $163 |
| 2020 | $86 | $87 | $33–$262 | $114 |
| 2021 | $0 | $94 | $31–$394 | $132 |
| 2022 | $22 | $125 | $45–$667 | $149 |
| 2023 | $0 | $143 | $44–$445 | $160 |
| 2024 | $0 | $122 | $40–$490 | $164 |
| 2025 | $0 | $140 | $52–$540 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 25 drugsPart D claims
812
Drug cost
$165,737
Branded share of claims
20.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ingrezza Valbenazine Tosylate | Brand | 15 | $128,270 | |
| Trintellix Vortioxetine Hydrobromide | Brand | 23 | $11,134 | |
| Lurasidone Hcl | Generic | 31 | $7,234 | |
| Paliperidone Er Paliperidone | Brand | 34 | $5,218 | |
| Methylphenidate Er (La) Methylphenidate Hcl | Brand | 21 | $2,568 | |
| Divalproex Sodium | Generic | 67 | $2,217 | |
| Quetiapine Fumarate | Generic | 95 | $1,333 | |
| Aripiprazole | Generic | 28 | $1,146 | |
| Bupropion Xl Bupropion Hcl | Brand | 37 | $939 | |
| Hydroxyzine Hcl | Generic | 35 | $898 |
The 10 drugs with the highest cost, of 25 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 5 billing codesPaid by Medicare
$15,086
Medicare patients
44
Services billed
158
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Depression | 75% | |
| Arthritis | 75% | |
| High blood pressure | 66% | |
| Diabetes | 25% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
19 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Addiction Medicine in Illinois
Roueen Rafeyan
Addiction Medicine · Chicago, IL
Leonard Spishakoff
Addiction Medicine · Romeoville, IL
Phillip Helding
Addiction Medicine · Hinsdale, IL
Neha Datta
Addiction Medicine · Orland Park, IL
Michael Rachman
Addiction Medicine · Schaumburg, IL
Kenneth Moore
Addiction Medicine · Burr Ridge, IL
Related records
Addiction Medicine in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Addiction Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.